| |
|
|
| Name: |
Foresite Capital Management IV LLC |
| City: |
San Francisco |
| State: |
CA |
| Zip: |
94111 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
7 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
PHVS |
Pharvaris N V Ord Shs |
1 |
- |
$0.00 |
$113,290,000 |
4,038,842 |
57.25% |
35,164,000 |
295,392 |
12.191 |
N/A |
|
|
KURA |
Kura Oncology Inc |
2 |
- |
$20.55 |
$26,602,000 |
1,849,947 |
13.44% |
9,730,000 |
0 |
2.429 |
N/A |
|
|
KNTE |
Kinnate Biopharma Inc. |
3 |
- |
$0.00 |
$22,922,000 |
9,671,643 |
11.58% |
9,382,000 |
0 |
22.126 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
4 |
- |
$22.38 |
$18,909,000 |
875,000 |
9.56% |
6,204,000 |
0 |
1.14 |
N/A |
|
|
LYEL |
Lyell Immunopharma, Inc. |
5 |
- |
$2.50 |
$16,151,000 |
8,325,000 |
8.16% |
3,237,000 |
-459,813 |
3.428 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
7 |
Closed |
$32.48 |
$0 |
0 |
0% |
-26,646,000 |
-1,787,094 |
0 |
N/A |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
6 |
Closed |
$1.22 |
$0 |
0 |
0% |
-19,235,000 |
-2,808,034 |
0 |
N/A |
|
